John Baron – 2014 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by John Baron on 2014-06-16.
To ask the Secretary of State for Health, what responsibilities clinical commissioning groups have for commissioning breast cancer services.
Jane Ellison
The majority of treatments for cancer, such as radiotherapy and chemotherapy, are commissioned nationally by NHS England. Commissioning is informed by a range of clinical reference groups established as a primary source of advice on best practice, service standards for commissioned providers and forward strategy and innovation.
Clinical commissioning groups (CCGs) plan and buy local community and non-specialised hospital cancer services in their local area. This includes the diagnosis, oversight of treatment and surgical management of breast cancers.
NHS England is not aware of any formal guidance being given to CCGs on engagement with Strategic Clinical Networks (SCNs) or breast network site-specific groups. However, it would expect that all health organisations would wish to be part of SCNs. As CCGs are responsible for much of the commissioning of services covered by the SCNs (e.g. cancer, stroke, mental health, and dementia care), they have an interest in their activities.
Breast network site specific groups are specialist groups who focus on protocol development, improving care and the quality and outcomes of services within the SCN area. It would not be expected for a CCG to normally engage directly with that group but they would be part of a process to approve protocols and of any escalation process if there were concerns about a particular service within the SCN.
National Institute for Health and Care Excellence (NICE) quality standards define clinical best practice for the diagnosis and treatment of breast cancer to help clinicians ensure that patients are given information about the treatment options available and help in choosing the best option to suit them. NHS England would expect CCGs to take into account NICE quality standards when commissioning breast cancer services.
